Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 555021 - 555040 out of 556109 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 7.5MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 5MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 5MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EE04) selumetinib | KOSELUGO 7.5MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 100MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EH04) zongertinib | HERNEXEOS 60MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 11MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 22MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 33MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 44MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 55MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
Pages
